Aspen Pharmacare Holdings (APN.JO) Akcija Kursas
Aspen Pharmacare Holdings Kursas
Per pastaruosius 19 metus Aspen Pharmacare Holdings pajamos augo 12,0 % kasmet ir pasiekė 34,87 mlrd. ZAR. Pelnas akcijai augo 6,1 % per metus per pastaruosius 19 metus. Aspen Pharmacare Holdings grynoji marža 7,6 % yra sumažėjo palyginti su 16,8 % prieš kelerius metus. Esama kaina dividendo pajamingumas yra apie 1,28 %. Išmokų koeficientas yra apie 28 % pelno. Dividendas augo 6,1 % per metus per pastaruosius 19 metus. Aspen Pharmacare Holdings 12 mėn. konsensuso tikslinė kaina yra 117,30 ZAR, apie žemiau kursą 28,7 %. Iš 10 analitikų 0 rekomenduoja pirkti — bendras konsensusas yra Laikyti.
Aspen Pharmacare Holdings akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Aspen Pharmacare Holdings akcija ir akcijų analizė
Dažnai užduodami klausimai apie Aspen Pharmacare Holdings akciją
The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.
Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.
The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.
Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.
Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.
Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.
Analitikai šiuo metu nustato vidutinę Aspen Pharmacare Holdings akcijos tikslinę kainą 120,02 ZAR (mediana: 117,30 ZAR), t. y. −27,0 % palyginti su paskutine kaina. Konsensusas pagrįstas 10 analitikų reitingais.
10 analitikai šiuo metu vertina Aspen Pharmacare Holdings akciją: 0 rekomenduoja pirkti, 6 laikyti ir 4 parduoti.
Pagal dabartinį kursą Aspen Pharmacare Holdings akcija kainuoja 8,84 EUR (164,45 ZAR).
Aspen Pharmacare Holdings akcija (APN.JO) kotiruojama 5 biržose, įskaitant: JSE (Johannesburg) (APN.JO), Frankfurt (LDZA.F), München (LDZA.MU), Düsseldorf (LDZA.DU).
Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.
pelnas Aspen Pharmacare Holdings yra 34,87 mlrd. ZAR. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
grynasis pelnas Aspen Pharmacare Holdings yra 2,65 mlrd. ZAR. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Aspen Pharmacare Holdings šiuo metu yra 27,55. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Aspen Pharmacare Holdings akcijos vertę.
Kainų ir pardavimų santykis (KUV) Aspen Pharmacare Holdings šiuo metu yra 2,09. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Aspen Pharmacare Holdings akcijos įvertinimo metrika.
Eulerpool kokybės balas Aspen Pharmacare Holdings yra 1/10.
Aspen Pharmacare Holdings ISIN yra ZAE000066692. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Aspen Pharmacare Holdings WKN yra A0ET80. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Aspen Pharmacare Holdings prekybos žymė yra APN.JO. Ši biržos žymė naudojama Aspen Pharmacare Holdings akcijoms prekiauti biržoje.
Aspen Pharmacare Holdings akcija
Aspen Pharmacare Holdings Pagrindiniai konkurentai
Aspen Pharmacare Holdings Biržos simbolis
Aspen Pharmacare Holdings FIGI
Visos Aspen Pharmacare Holdings pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Aspen Pharmacare Holdings akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Aspen Pharmacare Holdings. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: